Integrating Gender-Affirming Care in ED Treatment for Trans People
A systematic review emphasizes the need for comprehensive care addressing gender dysphoria and minority stressors in eating disorder treatments for trans individuals.
Trans People and Eating Disorders: A Systematic Review
A recent systematic review underscores the critical role of gender-affirming care in treating eating disorders (EDs) among trans and gender diverse individuals. This review, published on July 4, 2026, in OpenAlex, synthesizes findings from 18 peer-reviewed studies, highlighting both the improvements in disordered eating and the persistent mental health disparities in this population.
The research involved a comprehensive search across multiple databases, including ProQuest, Medline, and PsycINFO, focusing on terms related to gender diversity, EDs, and ED treatments. The findings reveal that while trans patients show reductions in disordered eating symptoms comparable to their cisgender peers, broader mental health issues, such as depression and suicidal ideation, remain prevalent.
The Role of Gender-Affirming Care
Gender-affirming medical care (GAMC) appears to play a significant role in the improvement of ED symptoms among trans individuals. Of the 24 trans patients included in case reports and series, 17 reported improvements in disordered eating, with 12 having accessed GAMC. Notably, five patients attributed their improvements exclusively to GAMC, suggesting its pivotal role in addressing both ED symptoms and underlying gender dysphoria.
This insight highlights the importance of integrating GAMC within ED treatment plans. By addressing gender dysphoria and minority stressors, healthcare providers can offer more comprehensive and effective care to trans patients.
Implications for Clinical Practice and Policy
The findings of this review have significant implications for clinical practice and policy-making in mental health services for trans communities. Integrating gender-affirming care into ED treatment not only addresses the immediate symptoms but also tackles the broader mental health challenges faced by trans individuals. This approach could lead to more sustainable recovery outcomes and improved overall mental health.
Policymakers and healthcare providers should consider these findings when designing treatment protocols and health policies aimed at supporting trans individuals. Ensuring access to comprehensive, gender-affirming care could significantly enhance the efficacy of ED treatments and reduce the mental health disparities faced by this population.
Risks and Unknowns in Treatment Outcomes
While the review provides valuable insights, several risks and unknowns remain. The persistence of mental health disparities, despite improvements in ED symptoms, indicates that current treatment approaches may not fully address the complex needs of trans individuals. Additionally, the variability in study quality, ranging from 0.7 to 1, suggests that further high-quality research is needed to fully understand the nuances of ED treatment in this population.
Moreover, the reliance on GAMC as a primary factor in symptom improvement raises questions about accessibility and equity in healthcare. Ensuring that all trans individuals have access to gender-affirming care is crucial for achieving equitable health outcomes.
Looking Ahead: Future Research and Policy Directions
Moving forward, there is a clear need for more comprehensive research that explores the intersection of gender identity, EDs, and mental health. Future studies should aim to include larger sample sizes and diverse populations to better understand the full spectrum of experiences among trans individuals.
Policymakers and healthcare providers must prioritize the integration of gender-affirming care in ED treatment protocols. By doing so, they can help mitigate the persistent mental health disparities and support the holistic well-being of trans individuals. This approach not only benefits the individual patients but also contributes to a more inclusive and equitable healthcare system.
Get tomorrow's briefing in your inbox
Policy, research, and regulatory signal — delivered on our publish cadence.